Trump reaches agreement with E.U. to impose 15% tariff, with exceptions for key industries

The U.S. and E.U. have reached a trade agreement setting a 15% tariff on E.U. imports into the U.S., a reduction from the previously threatened 30% but still higher than historical averages. This deal, aimed at stabilizing transatlantic trade, includes zero tariffs on key sectors such as aircraft, generic pharmaceuticals, and semiconductor equipment, with the E.U. committing to purchase $750 billion in U.S. energy over three years. While averting a major trade conflict that would have significantly impacted export-oriented economies like Germany, particularly its automotive industry, 50% steel tariffs remain, and new tariffs on pharmaceuticals and semiconductors are still being considered.

Analysis

The US-EU trade agreement establishes a new 15% general tariff on European Union imports, a significant de-escalation from the threatened 30% but a substantial increase from the historical average of 1.2%. While this pact averts a near-term trade war, which had prompted the EU to prepare $100 billion in retaliatory tariffs, it institutionalizes a higher-cost trade environment. Key sectors have received specific carve-outs, with zero tariffs applied to all aircraft, generic pharmaceuticals, and semiconductor equipment, which is a direct positive for companies like Boeing (BA) that also avoid retaliatory measures. The deal is particularly beneficial for the German automotive industry, as it nearly halves the effective tariff on its vehicles from 27.5% to 15%. Furthermore, the agreement includes a major EU commitment to purchase $750 billion in U.S. energy and invest $600 billion in the U.S., signaling a strategic shift in supply chains away from Russia. However, significant risks and uncertainties persist. The pre-existing 50% tariff on steel remains unchanged, and the agreement does not resolve the threat of future tariffs on pharmaceuticals, where a 200% tariff was previously mentioned, or on semiconductors, which could be announced in the coming weeks.

Key Decisions for Investors

• Investors should view this agreement as a net positive for European automakers, particularly German manufacturers, as the tariff rate is substantially reduced from 27.5% to 15%, alleviating significant margin pressure.
• The combination of zero tariffs on aircraft and the removal of retaliatory threats from the EU provides a bullish catalyst for U.S. aerospace manufacturers like Boeing (BA).
• The EU's firm commitment to purchase $750 billion in U.S. energy creates a long-term, secular demand driver for U.S. liquified natural gas, oil, and nuclear fuel exporters.
• Caution is warranted for investments in the pharmaceutical sector, especially those with significant Irish manufacturing exposure, as the threat of steep tariffs remains unresolved, and investors should also monitor for potential new tariffs on semiconductors.